| Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling MC Brown, MM Mosaheb, M Mohme, ZP McKay, EK Holl, JP Kastan, ... Nature Communications 12 (1), 1858, 2021 | 51 | 2021 |
| Aryl hydrocarbon receptor signaling controls CD155 expression on macrophages and mediates tumor immunosuppression ZP McKay, MC Brown, M Gromeier The Journal of Immunology 206 (6), 1385-1394, 2021 | 21 | 2021 |
| Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial EM Thompson, D Landi, MC Brown, HS Friedman, R McLendon, ... The Lancet Child & Adolescent Health 7 (7), 471-478, 2023 | 13 | 2023 |
| CD155 is a putative therapeutic target in medulloblastoma S Li, R McLendon, E Sankey, R Kornahrens, AM Lyne, FMG Cavalli, ... Clinical and Translational Oncology 25 (3), 696-705, 2023 | 4 | 2023 |
| PKR binds enterovirus IRESs, displaces host translation factors, and impairs viral translation to enable innate antiviral signaling MI Dobrikov, EY Dobrikova, ZP McKay, JP Kastan, MC Brown, ... Mbio 13 (3), e00854-22, 2022 | 4 | 2022 |
| Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils MC Brown, GM Beasley, ZP McKay, Y Yang, A Desjardins, DM Randazzo, ... Journal for Immunotherapy of Cancer 11 (4), 2023 | 3 | 2023 |
| IMMU-43. CXCR3 signaling engages glioma infiltrating T cells and is required for the antitumor efficacy of innate stimulating immunotherapy M Brown, Y Yang, Z Mckay, D Bigner, D Ashley, M Gromeier, S Nair Neuro-Oncology 24 (Suppl 7), vii140, 2022 | 1 | 2022 |
| Intratumor Childhood Vaccine-Specific CD4+ T cell Recall Coordinates Antitumor CD8+ T cells and Eosinophils MC Brown, ZP McKay, Y Yang, GM Beasley, DM Ashley, DD Bigner, ... bioRxiv, 2022.03. 14.484260, 2022 | 1 | 2022 |
| 739 Intratumor childhood vaccine-specific CD4+ T cell recall helps antitumor CD8 T cells M Brown, Z McKay, Y Yang, D Bigner, S Nair, M Gromeier Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A770-A770, 2021 | 1 | 2021 |
| Safety and efficacy of murine PVSRIPO plus anti-PD-1 immune checkpoint inhibitor (ICI) in a melanoma tumor model. L Neighbours, ZP McKay, M Gromeier, G Nichols, AT Kelly, D Corum, ... Journal of Clinical Oncology 39 (15_suppl), 2560-2560, 2021 | 1 | 2021 |
| Early enterovirus translation deficits extend viral RNA replication and elicit sustained MDA5-directed innate signaling MI Dobrikov, EY Dobrikova, DT Nardone-White, ZP McKay, MC Brown, ... Mbio 14 (6), e01915-23, 2023 | | 2023 |
| Childhood vaccine-specific CD4+T cell recall coordinates antitumor type I and II immunity MC Brown, ZP Mckay, Y Yang, DD Bigner, SK Nair, M Gromeier Cancer Research 82 (12_Supplement), 2073-2073, 2022 | | 2022 |
